| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 664029 | 61874 | TOPAMAX 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | TOPAMAX 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 60 comprimidos | 50 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61874/61874_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61874/61874_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71060 | JANSSEN CILAG S.A. | 1998-05-01 | 1 | 1 | 1 | 1998-05-01 | 1998-05-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 664037 | 61873 | TOPAMAX 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | TOPAMAX 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 60 comprimidos | 25 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61873/61873_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61873/61873_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71060 | JANSSEN CILAG S.A. | 1998-05-01 | 1 | 1 | 1 | 1998-05-01 | 1998-05-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 664459 | 71779 | RIVASTIGMINA VIR 2 mg/ml SOLUCION ORAL EFG | RIVASTIGMINA VIR 2 mg/ml SOLUCION ORAL EFG , 1 frasco de 120 ml con jeringa dosificadora | 2 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml, con jeringa dosificadora | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71779/71779_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71779/71779_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2009-12-16 | 1 | 1 | 1 | 2009-12-16 | 2009-12-16 | 1 | 2012-10-18 | View Edit Delete | ||||||||||||
| 664461 | 71781 | RIVASTIGMINA ORTODROL 2 mg/ml SOLUCION ORAL EFG | RIVASTIGMINA ORTODROL 2 mg/ml SOLUCION ORAL EFG, 1 frasco de 120 ml con jeringa dosificadora | 2 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml, con jeringa dosificadora | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71781/71781_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71781/71781_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2009-12-16 | 1 | 1 | 1 | 2009-12-16 | 2009-12-16 | 1 | 2011-04-14 | View Edit Delete | ||||||||||||
| 665364 | 61617 | ADOLONTA 100 mg/ ml SOLUCION ORAL | ADOLONTA 100 mg/ ml SOLUCION ORAL , 1 frasco de 30 ml | 100 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61617/61617_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61617/61617_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | GRÜNENTHAL PHARMA S.A. | 1998-02-01 | 1 | 1 | 1 | 1998-02-01 | 1998-02-01 | 1 | 2011-10-13 | View Edit Delete | ||||||||||||
| 664153 | 71576 | VIGAMOX 5 mg/ml COLIRIO EN SOLUCION | VIGAMOX 5 mg/ml COLIRIO EN SOLUCION , 1 frasco de 5 ml | 5 mg/ml | 6 | 5 | 26 | 1 frasco de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71576/71576_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71576/71576_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 2009-10-26 | 1 | 1 | 1 | 2009-10-26 | 2009-10-26 | 1 | 2011-11-08 | View Edit Delete | ||||||||||||
| 664929 | 72005 | SEHCAT 370 KBQ CAPSULAS | SEHCAT 370 KBQ CAPSULAS, 1 cápsula | 370 kBq | 6 | 1 | 43 | 1 cápsula | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72005/72005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72005/72005_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 10603 | GE HEALTHCARE BIO-SCIENCES, S.A.U. | 2010-03-24 | 1 | 1 | 1 | 2010-03-24 | 2010-03-24 | 1 | 2011-10-10 | View Edit Delete | ||||||||||||
| 664496 | 71816 | RIVASTIGMINA CINFA 2 mg/ml SOLUCION ORAL EFG | RIVASTIGMINA CINFA 2 mg/ml SOLUCION ORAL EFG , 1 frasco de 120 ml con jeringa dosificadora | 2 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml, con jeringa dosificadora | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71816/71816_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71816/71816_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2010-01-14 | 1 | 1 | 1 | 2010-01-14 | 2010-01-14 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 664267 | 68004 | APIROFENO 40 mg/ml SUSPENSION ORAL | APIROFENO 40 mg/ml SUSPENSION ORAL , 1 frasco de 50 ml | 40 mg/ml | 6 | 50 | 26 | 1 frasco de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68004/68004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68004/68004_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 2006-08-29 | 1 | 1 | 1 | 2006-08-29 | 2009-11-19 | 1 | 2011-09-09 | View Edit Delete | ||||||||||||
| 664683 | 71639 | MASTICAL D UNIDIA 1000 MG/800 UI COMPRIMIDOS MASTICABLES | MASTICAL D UNIDIA 1000 MG/800 UI COMPRIMIDOS MASTICABLES, 30 comprimidos | 2.500 mg (1.000 mg Ca)/800 UI | 6 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71639/71639_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71639/71639_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25535 | LABORATORIOS RUBIO S.A. | 2010-02-02 | 1 | 1 | 1 | 2010-02-02 | 2010-02-02 | 1 | 2011-09-13 | View Edit Delete | ||||||||||||
| 664148 | 71501 | OCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION | OCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 50 ml | 100 mg/ml inyectable 50 ml | 6 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71501/71501_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71501/71501_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5237 | OCTAPHARMA S.A. | 2009-11-02 | 1 | 1 | 1 | 2009-11-02 | 2009-11-02 | 0 | 2011-06-02 | View Edit Delete | ||||||||||||
| 664149 | 71501 | OCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION | OCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 200 ml | 100 mg/ml inyectable 200 ml | 6 | 1 | 34 | 1 vial de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71501/71501_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71501/71501_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5237 | OCTAPHARMA S.A. | 2009-11-02 | 1 | 1 | 1 | 2009-11-02 | 2009-11-02 | 0 | 2011-06-02 | View Edit Delete | ||||||||||||
| 664150 | 71501 | OCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION | OCTAGAMOCTA 100 mg/ml SOLUCION PARA PERFUSION , 1 vial de 100 ml | 100 mg/ml inyectable 100 ml | 6 | 1 | 34 | 1 vial de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71501/71501_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71501/71501_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5237 | OCTAPHARMA S.A. | 2009-11-02 | 1 | 1 | 1 | 2009-11-02 | 2009-11-02 | 0 | 2011-06-02 | View Edit Delete | ||||||||||||
| 665381 | 72302 | PANTOPRAZOL TARBIS 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL TARBIS 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (FRASCO) | 20 mg | 6 | 28 | 10 | 28 comprimidos (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72302/72302_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72302/72302_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2010-05-26 | 1 | 1 | 1 | 2010-05-26 | 2010-05-26 | 1 | 2015-07-07 | View Edit Delete | ||||||||||||
| 665382 | 72300 | PANTOPRAZOL TARBIS 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL TARBIS 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (FRASCO) | 40 mg | 6 | 28 | 10 | 28 comprimidos (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72300/72300_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72300/72300_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2010-05-26 | 1 | 1 | 1 | 2010-05-26 | 2010-05-26 | 1 | 2015-07-07 | View Edit Delete | ||||||||||||
| 665399 | 72299 | PANTOPRAZOL TEVA-RATIO 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL TEVA-RATIO 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (FRASCO) | 20 mg | 6 | 28 | 10 | 28 comprimidos (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72299/72299_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72299/72299_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2010-05-26 | 1 | 1 | 1 | 2010-05-26 | 2010-05-26 | 1 | 2016-09-12 | View Edit Delete | ||||||||||||
| 665401 | 72298 | PANTOPRAZOL TEVA-RATIO 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL TEVA-RATIO 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (FRASCO) | 40 mg | 6 | 28 | 10 | 28 comprimidos (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72298/72298_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72298/72298_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2010-05-26 | 1 | 1 | 1 | 2010-05-26 | 2010-05-26 | 1 | 2016-09-12 | View Edit Delete | ||||||||||||
| 664463 | 71778 | RIVASTIGMINA KERN PHARMA 2 mg/ml SOLUCION ORAL EFG | RIVASTIGMINA KERN PHARMA 2 mg/ml SOLUCION ORAL EFG , 1 frasco de 120 ml con jeringa dosificadora | 2 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml con jeringa dosificdora | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71778/71778_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71778/71778_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2009-12-16 | 1 | 1 | 1 | 2009-12-16 | 2009-12-16 | 1 | 2012-09-19 | View Edit Delete | ||||||||||||
| 665067 | 61812 | DICLOFENACO-LEPORI 1 MG/ML COLIRIO EN SOLUCIÓN | DICLOFENACO-LEPORI 1 MG/ML COLIRIO EN SOLUCIÓN , 1 frasco de 5 ml | 1 mg/ml | 6 | 5 | 26 | 1 frasco de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61812/61812_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61812/61812_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39341 | ANGELINI PHARMA ESPANA S.L. | 1998-02-01 | 1 | 1 | 1 | 1998-02-01 | 1998-02-01 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 664565 | 61848 | ATROVENT NASAL 0,30 mg/ml SOLUCION PARA PULVERIZACION NASAL | ATROVENT NASAL 0,30 mg/ml SOLUCION PARA PULVERIZACION NASAL, 1 envase pulverizador de 15 ml | 0,3 mg/ml | 6 | 15 | 26 | 1 envase pulverizador de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61848/61848_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61848/61848_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 1998-05-01 | 1 | 1 | 1 | 1998-05-01 | 1998-05-01 | 1 | 2011-10-25 | View Edit Delete |
Page 275 of 1036, showing 20 records out of 20704 total, starting on record 5481, ending on 5500